|
|||||
|
|
Population pharmacokinetics of a new long‐acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B |
|
| Authors: | Y. Zhang J. Roberts D. Bensen‐Kennedy I. Jacobs E. Santagostino C. Voigt A. Feussner M. Morfini J. Sidhu |
| Affiliation: | 1. Clinical Pharmacology and Early Development, CSL Behring, King of Prussia, PA, USA;2. IRCCS Ca' Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy;3. Department of Preclinical Research and Development, CSL Behring GmbH, Marburg, Germany;4. Haemophilia Centre, University Hospital of Florence, Florence, Italy;5. Clinical Pharmacology and Early Development, CSL Limited, Parkville, Australia |
| Abstract: | |
| Keywords: | children factor IX hemophilia B pharmacokinetics recombinant proteins |